Corbion
Corbion secures Chinese regulatory approvals for algae-derived Omega-3 DHA products in human and animal nutrition
Corbion secures Chinese regulatory approvals for algae-derived Omega-3 DHA products in human and animal nutrition
Corbion, a global leader in sustainable ingredient solutions, has successfully secured multiple regulatory approvals from China’s General Administration of Customs (GACC) paving the way for offering Corbion’s high quality, sustainable, algae-derived omega-3 DHA solutions in China’s fast-growing human and animal nutrition segments.
Corbion received several crucial registrations from GACC for its omega-3 products, marketed under the AlgaPrime™ DHA and AlgaVia™ DHA brands. Both brands are premium algae-derived omega-3 products designed to meet the growing demand for high-quality animal nutrition as well as plant-based human nutrition and nutraceutical solutions in China. With all regulatory steps now completed, Corbion is ready to bring its algae-derived nutrition solutions to market in China across both human and animal applications, where demand for sustainable and traceable ingredients continues to increase.
“China is an important and fast-growing market for algae-derived omega-3 solutions in both food and feed,” said Tim Rutten, Vice President Nutrition & Pharma at Corbion. “With these registrations and licenses in place, we can now offer Chinese customers and partners our proven ingredients that align with their focus on quality, safety, and sustainability.”
AlgaVia™ DHA and AlgaPrime™ DHA
Corbion’s AlgaVia™ DHA and AlgaPrime™ DHA deliver a clean, highly concentrated, and sustainable source of omega-3 DHA. They are produced on land from microalgae via controlled fermentation using sugar cane and renewable energy, thereby reducing reliance on marine resources and carbon footprint at the same time. Trusted by leading brands in human nutrition, aquaculture, livestock, and pet food, these solutions enhance omega-3 profiles and supply chain resilience amid rising global demand. Driven by its commitment to quality, reliability, sustainability, and adaptability, Corbion delivers more than just omega-3 ingredients, it delivers flexible solutions tailored to diverse customer needs. Whether in powder, liquid suspension, or oil format, its algae-based omega-3 solutions fit into a wide range of applications across human and animal nutrition.
For more information, please contact:
Press:
Lucas Jan Wiarda, Strategic Marketing Health & Nutrition
+31(0)6 10334360
Analysts and investors:
Alex Sokolowski, Head of Investor Relations
+31(0)6 46941365
Background information:
Corbion is a sustainable ingredients company dedicated to preserving what matters, including food and food production, health, and the planet. We specialize in lactic acid, lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients, using our deep application and product knowledge to propel nature’s ingenuity through science. With more than a century of experience, we continue working side-by-side with our customers to make our cutting-edge technologies work for them. Leveraging our advanced capabilities in fermentation and preservation technology, we help customers differentiate their products in diverse markets ranging from food and animal nutrition to home & personal care, pharmaceuticals, electronics, medical devices, and bioplastics. In 2024, Corbion generated annual sales of € 1,332.0 million with a workforce of 2,399 FTEs. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Baltic Horizon Fund / Northern Horizon Capital8.7.2025 15:15:00 CEST | Press release
Application for delisting of SDRs from Nasdaq Stockholm
Nokia Oyj8.7.2025 15:00:00 CEST | Press release
Nokia Corporation - Managers' transactions (Heard)
CGTN8.7.2025 14:39:06 CEST | Pressemeddelelse
CGTN: Hvordan styrker BRIKS+ det globale syd?
Cellebrite DI Ltd8.7.2025 14:30:00 CEST | Press release
Cellebrite Names David Barter Chief Financial Officer
Danske Invest8.7.2025 14:25:31 CEST | Pressemeddelelse
Correction: Finanstilsynets godkendelse af fusion af afdelinger under Investeringsforeningen Danske Invest
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom